Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan Hildesheim

Showing results (41-50 of 360) with videos related to

Pageof 36
Sort By:
Cytokine|March 7, 2017
Impact of freeze-thaw cycles on circulating inflammation marker measurementsWen-Yi Huang, Troy J Kemp, Ruth M Pfeiffer, et al.
American Journal of Epidemiology|April 5, 2024
Gallbladder cancer mortality in Chile: has the government program targeting young gallstone patients had an impact?Vicente Cid, Claudio Vargas, Iris Delgado, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particlesFatma M Shebl, Ligia A Pinto, Alfonso García-Piñeres, et al.
Journal of the National Cancer Institute|March 28, 2008
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infectionsAna Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, et al.
Journal of the National Cancer Institute|August 7, 2003
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesDenise Nardelli-Haefliger, Daniel Wirthner, John T Schiller, et al.
The Journal of Infectious Diseases|May 3, 2018
Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical TrialsMahboobeh Safaeian, Xavier Castellsagué, Allan Hildesheim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 11, 2009
Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young womenCarolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, et al.
European Journal of Immunology|December 31, 2005
Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccineAlfonso J García-Piñeres, Allan Hildesheim, Matthew Trivett, et al.
Cancer|March 3, 2018
Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for researchAimée R Kreimer, Meredith S Shiels, Carole Fakhry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Simultaneous measurement of several cytokines using small volumes of biospecimensAllan Hildesheim, Rick L Ryan, Elizabeth Rinehart, et al.
Pageof 36

Showing results (41-50 of 360) with videos related to

Sort By:
Pageof 36
Cytokine|March 7, 2017
Impact of freeze-thaw cycles on circulating inflammation marker measurementsWen-Yi Huang, Troy J Kemp, Ruth M Pfeiffer, et al.
American Journal of Epidemiology|April 5, 2024
Gallbladder cancer mortality in Chile: has the government program targeting young gallstone patients had an impact?Vicente Cid, Claudio Vargas, Iris Delgado, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particlesFatma M Shebl, Ligia A Pinto, Alfonso García-Piñeres, et al.
Journal of the National Cancer Institute|March 28, 2008
Rapid clearance of human papillomavirus and implications for clinical focus on persistent infectionsAna Cecilia Rodríguez, Mark Schiffman, Rolando Herrero, et al.
Journal of the National Cancer Institute|August 7, 2003
Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particlesDenise Nardelli-Haefliger, Daniel Wirthner, John T Schiller, et al.
The Journal of Infectious Diseases|May 3, 2018
Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical TrialsMahboobeh Safaeian, Xavier Castellsagué, Allan Hildesheim, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 11, 2009
Human papillomavirus types by age in cervical cancer precursors: predominance of human papillomavirus 16 in young womenCarolina Porras, Ana Cecilia Rodríguez, Allan Hildesheim, et al.
European Journal of Immunology|December 31, 2005
Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccineAlfonso J García-Piñeres, Allan Hildesheim, Matthew Trivett, et al.
Cancer|March 3, 2018
Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for researchAimée R Kreimer, Meredith S Shiels, Carole Fakhry, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 16, 2002
Simultaneous measurement of several cytokines using small volumes of biospecimensAllan Hildesheim, Rick L Ryan, Elizabeth Rinehart, et al.
Pageof 36